Entinostat finds a path: A new study elucidates effects of the histone deacetylase inhibitor on the immune system
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Entinostat finds a path: A new study elucidates effects of the histone deacetylase inhibitor on the immune system
Authors
Keywords
-
Journal
CANCER
Volume 124, Issue 24, Pages 4597-4600
Publisher
Wiley
Online
2018-11-14
DOI
10.1002/cncr.31766
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cooperativity of HOXA5 and STAT3 Is Critical for HDAC8 Inhibition-Mediated Transcriptional Activation of PD-L1 in Human Melanoma Cells
- (2018) Yu Fang Wang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The antitumor effects of entinostat in ovarian cancer require adaptive immunity
- (2018) Haller J. Smith et al. CANCER
- HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody in vivo
- (2017) Laurence Booth et al. Oncotarget
- Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth
- (2017) Taylor B. Turner et al. Oncotarget
- CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma
- (2016) J. Walton et al. CANCER RESEARCH
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy
- (2015) M. Maio et al. CLINICAL CANCER RESEARCH
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin
- (2014) Victoria L. Luchenko et al. Molecular Oncology
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
- (2013) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia
- (2011) M. J. Bishton et al. BLOOD
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- Cytotoxicity Mediated by Histone Deacetylase Inhibitors in Cancer Cells: Mechanisms and Potential Clinical Implications
- (2009) D. S. Schrump CLINICAL CANCER RESEARCH
- Multiple roles of HDAC inhibition in neurodegenerative conditions
- (2009) De-Maw Chuang et al. TRENDS IN NEUROSCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started